natalynn

Thanks guys,
I let this thought go... we wont dont it.
Instead we'll warm up a bottle for use in prewarm procedure then toss it after.

Thanks guys,
I let this thought go... we wont dont it.
Instead we'll warm up a bottle for use in prewarm procedure then toss it after.

Exlimey,
Sorry to get back to you so late, but I don’t even know that you need my 2 cense now, everyone seemed to cover my thoughts already.
 
Since (little) k is so rare it will not hurt to check for it on your patients and give (little) k negative units to the few (if any) that are negative for the antigen.
We do a molecular genotype on our Darzalex patients before they receive their first treatment, so we have their K and k results in hand ready if need be.

Exlimey,
Sorry to get back to you so late, but I don’t even know that you need my 2 cense now, everyone seemed to cover my thoughts already.
 
Since (little) k is so rare it will not hurt to check for it on your patients and give (little) k negative units to the few (if any) that are negative for the antigen.
We do a molecular genotype on our Darzalex patients before they receive their first treatment, so we have their K and k results in hand ready if need be.

John, I do wish you would offer your services to TJC and other agencies. They have a severe lack of knowledge when it comes to BB issues. We would bow down and pay you hommage. Blood Bankers across the country would sing your praises. Your name would be spoken with reverence. (I know it is getting deep)
 
I was cited by CAP in 2013 for using expired panel cells. I challenged it and said we did not use them routinely, only as an aid in identification when the in-date panels couldn't provide what was needed to complete an ID. I also started having my people run a positive with the patient's serum on the same panel to show that the antibody would be detected using the method (gel or tube). It was expunged, thank goodness. I think CAP has a much better understanding of the situation than TJC. 

If the patient is k negative based on genotype be sure to be giving k negative units!
 
We only have 1 departmentalized blood banker at the moment and we have brought in DTT testing for these patients. Its MUCH more cost effective to do it in house rather than send out, and if the pt screen is negative well then IS or EXM (K negative or k negative depending on their genotype) is much cheaper than phenotypically matched products!

TRM.31250 Reagent Expiration Dates Phase II
All reagents are used within their indicated expiration date.
NOTE: Rare reagents may be used beyond their expiration date if appropriate positive and negative
controls are run each day of use and react as expected. This exception is permitted by the FDA.
This does NOT apply to reagents that are readily available. The laboratory should establish criteria
defining which reagents are considered “rare.”
 
Write a procedure identifying what your criteria is for rare/unavailable, how you ensure QC is appropriate/acceptable, have your medical director approve it and you should be good to hook.

Why don't you just validate the antisera for use with gel.  You can use the buffered gel tubes and only 25uL of antisera (or 50 if you want to).  You just have to validate that the antisera work in gel (they do) and have a good procedure.   
 
If you want to turn gel cells into 3% cell suspensions you will need at least 5 drops washed to a dry button and resuspended in saline (or whatever you use).  Ortho says 4 drops but I find the button too small and do not do this at all.
 
You can extend the life of the antisera to your comfort level as long as the qc works (theoretically).  CAP and the FDA say you can do this so you can

I agree with David regarding the antisera, but I would like to emphasize having a procedure, specificaly stating what antisera you will save, what conditions you wouldn't use it (like discoloration) and things like that. CAP will like that.

That sounds like a very nice quote - my statistics are similar to yours, a few more panels and transfusions and a lot less T&S. Personally, I like HCLL - moderately expensive but worth it (to me) - I looked at Psyche's SBB, McKesson's Horizon (which is Wyndgate's Transfusion module), I know some folks that really like the Soft product; Meditech is good also.
Make certain that what you purchase satisfies your needs with little "extra" effort on your part (like having to register and discharge pts routinely). Another kudo is don't use the validation templates provided but develop your own that mirror your operation. This is a bit time consuming but worth it in the long run as you will find all the "bugs" in your installation and can have them fixed to your liking before you go live. The FDA will want to look at your data - or at least see that you have reams of paper that validate your system.
Good luck.

I manage a small 21 bed hospitals blood bank. There has recently been talk about letting us purchase a computer system for our blood bank. Currently we are using a logbook to record all reaction, and then inputting the results (not reactions) into our LIS.
 
Does anyone know of an afordable software available for such a small hospital?
Heres some numbers that may be helpful in determening what might suit us best:
Our monthly averages
T&S 300
antibody pannels 2
crossmatches 80
transfussions 7
 
We've gotten one quote for 12,000 instal, 1,500 per month, and that is not including the cost to intergrade with out LIS system for the lab. 
 
Thanks